Pharmaceutical Care Management Association
Pharmacy middlemen sue to stop rebate transparency
An industry group representing powerful drug middlemen has gone to court to stop a federal rule intended to bring transparency to rebates middlemen get from manufacturers. The middlemen are arguing that the rule, initiated by the Trump administration, will increase drug costs. But the group’s critics say that secretive rebates are a primary driver of […]
Drug-pricing practice could be banned to help pay for infrastructure bill
Drug-pricing practice could be banned to help pay for infrastructure bill.
Big PBM decision undergoes its first test
The stakes appear to be pretty high. After a unanimous ruling in a related case in December, the U.S. Supreme Court has reopened a case regarding sweeping regulations of powerful middlemen known as pharmacy benefit managers — and 30 state attorneys general and many others are joining the fray. Pharmacy benefit managers, or PBMs, are […]
To a growing number of pharmacists, using insurance to pay for most generic drugs makes about as much sense as getting auto insurance to cover your oil changes. Problem is, if you try to buy generics without using your insurance card at the vast, vast majority of American pharmacies, you’re going to pay a “cash” […]
Antitrust concerns are increasing on Capitol Hill. Advocates say they should extend to drug pricing
Antitrust concerns are increasing on Capitol Hill. Advocates say they should extend to drug pricing.